Laboratorios Farmaceuticos Rovi, S.A./ADR (LABFF) — Earnings Call Analysis & IR Page

Laboratorios Farmaceuticos Rovi, S.A./ADR is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $3.44B market cap.

Most recent earnings call: Q1 FY26 on May 9, 2026.

7 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

IR URL not yet extracted for LABFF.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 7 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LABFF.

$ curl https://api.spokenalpha.com/v1/companies/LABFF

Get an API key API docs

FAQ

Frequently asked about LABFF

Where can I find Laboratorios Farmaceuticos Rovi, S.A./ADR's (LABFF) earnings call transcripts?

Spoken Alpha indexes LABFF's earnings call transcripts at https://spokenalpha.com/companies/LABFF. Each call links to attributed speakers and parsed analyst Q&A.

When was Laboratorios Farmaceuticos Rovi, S.A./ADR's most recent earnings call?

Laboratorios Farmaceuticos Rovi, S.A./ADR (LABFF) held its most recent earnings call on 2026-05-09, covering fiscal Q1 2026.

What sector is LABFF in?

Laboratorios Farmaceuticos Rovi, S.A./ADR (LABFF) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

Overview